Stay updated on Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial

Sign up to get notified when there's something new on the Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added and the previous Revision: v3.5.3 was removed, reflecting an update to the page's revision history.
    Difference
    0.0%
    Check dated 2026-05-15T05:39:03.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s interface/display revision was updated from **v3.5.2** to **v3.5.3**, indicating a site version change rather than a change to the underlying study information.
    Difference
    0.0%
    Check dated 2026-04-24T06:36:22.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:52:21.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Updated the listed location from Padua, PD, Italy, 35128 to Padova, PD, Italy, 35128.
    Difference
    0.0%
    Check dated 2026-04-09T21:53:03.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-03-19T08:35:44.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T04:44:54.000Z thumbnail image

Stay in the know with updates to Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial page.